CTLA-4 ANTIBODY AND AROMATASE INHIBITOR OR COMBINATION TREATMENT FOR BREAST CANCER - Patent 1819735

(19)

(11)

EP 1 819 735 A1

(12)

(43)	Date of publication:
	22.08.2007 Bulletin 2007/34

(21)	Application number: 05798369.4

(22)	Date of filing: 24.10.2005

(51)

International Patent Classification (IPC):

C07K 16/28^(2006.01)

A61K 39/395^(2006.01)

(86)	International application number:
	PCT/IB2005/003307

(87)	International publication number:
	WO 2006/048749 (11.05.2006 Gazette 2006/19)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

04.11.2004 US 624856 P

(71)	Applicant: Pfizer Products Inc.
	Groton, CT 06340 (US)

(72)	Inventor:
	GOMEZ-NAVARRO, Jesus, Pfizer Global R & D New London, CT 06320 (US)

(74)	Representative: Rutt, Jason Edward et al
	Pfizer Limited European Patents Department, Ramsgate Road Sandwich, Kent CT13 9NJ Sandwich, Kent CT13 9NJ (GB)

(54)	CTLA-4 ANTIBODY AND AROMATASE INHIBITOR OR COMBINATION TREATMENT FOR BREAST CANCER